Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
| CAPS Rating |
|
|---|---|
| Open | $14.65 |
| Previous Close | $14.47 |
| Daily Range | $14.19 - $15.43 |
| 52-Week Range | $9.00 - $16.24 |
| Market Cap | $289.19M |
| P/E Ratio | 226.50 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 359,522 |
| Average Daily Volume | 0 |
LGND
VS S&P 500 (SPY)
How do you think LGND will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
LGND Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
LGND News and Commentary
- Ligand Pharmaceuticals Crushes Estimates – The Motley Fool
- Pfizer To Seek FDA Approval For Long-Stalled Menopause Drug – SmartMoney
- Why Did My Stock Just Die? – The Motley Fool
- 3 "Insider" Stocks to Watch this Earnings Season – NASDAQ
- Reshuffling Yahoo!'s Board: A New House of Cards? – The Motley Fool
- 3 Stocks Near 52-Week Highs Worth Selling – The Motley Fool
- 12 Biotech Stocks the Insiders Are Buying – The Motley Fool
- AllStarPortfolio - Back in the saddle (ping rhallbick and Bays) – Blog at The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Low-Priced Biotech Stocks With Insider Buying – SeekingAlpha
- 6 Stocks With Substantial Insider Buying – SeekingAlpha
- Glaxo Gets EU Approval To Sell Blood Platelet Booster Revolade – SmartMoney
- GlaxoSmithKline: EC Gives Marketing Authorization For Revolade – SmartMoney
- Best and Brightest small cap companies to be showcased at first ever conference In San Francisco – Blog at The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- Sniffing around for more bottoms – Blog at The Motley Fool
- GOOD and BAD Biotechs: One year later (part III) – Blog at The Motley Fool
- 5 Top Stocks at Half Price – The Motley Fool
- DARA—Time to Harvest – Blog at The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
RSS Headlines
Fool UK
